Reports for APOTEX INC
Company Name APOTEX INC |
||
---|---|---|
Totals |
||
Shortage reports |
3367 |
|
Actual shortage: | 219 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3138 (93%) | |
Discontinuation Reports |
365 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 341 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
68 (28%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TADALAFIL | 10MG | TABLET | Resolved | 2019-03-20 | 2019-04-26 | 79051 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2019-07-03 | 2020-02-03 | 88368 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2019-07-17 | 2020-01-10 | 89551 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2019-08-23 | 2020-01-22 | 92387 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2020-03-04 | 2020-04-07 | 107717 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2020-10-28 | 2021-01-26 | 127376 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2018-04-02 | 2018-05-15 | 44520 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-01-05 | 2024-03-08 | 215227 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2024-01-05 | 2024-03-08 | 215239 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2024-01-05 | 2024-01-26 | 215242 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2024-03-08 | 2024-05-03 | 221705 |
APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-04-19 | 2024-05-31 | 225773 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2024-04-19 | 2024-05-10 | 225790 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2023-08-04 | 2023-09-07 | 201165 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2023-10-27 | 2023-11-24 | 208373 |
APO-TADALAFIL | 10MG | TABLET | Resolved | 2023-10-27 | 2023-11-24 | 208403 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2023-11-24 | 2023-12-22 | 211478 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2022-02-18 | 2022-04-18 | 155321 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2024-04-19 | 2024-05-03 | 225785 |
APO-TADALAFIL PAH | 20MG | TABLET | Resolved | 2020-02-05 | 2020-06-02 | 105356 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CIPROFLOX | 750MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60388 |
APO-CITALOPRAM | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60393 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |
APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
APO-CLONAZEPAM - TAB 0.5MG | .5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60402 |
APO-CYCLOBENZAPRINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60405 |
APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-08-07 | 2019-08-07 | 91117 |
APO-DICLO | 50MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-07 | 2019-08-08 | 60420 |
APO-DICLO RAPIDE 50 MG TABLETS | 50MG | TABLET | To be discontinued | 2018-09-07 | 2018-11-02 | 60423 |
APO-DICLO SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4909 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-DICLOFENAC OPHTHALMIC | 0.1% | SOLUTION | Discontinued | 2018-09-07 | 2019-02-13 | 60426 |
APO-DILTIAZ CD | 300MG | CAPSULE (CONTROLLED-DELIVERY) | Discontinued | 2019-02-01 | 2019-02-02 | 74366 |
APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
APO-DILTIAZ TZ | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1069 |
APO-DILTIAZ TZ | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1072 |
APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |